Hoffmann, M. S., Nowakowski, G. S., Kwiatek, M., Bouzani, M., Zimowska-Curylo, D., Moustafa, M. A., Garcia-Sancho, A. M., Sancho, J., Jurczak, W., Patel, A., Boucaud, F., Gkasiamis, A., Kaplan, M., Amzallag, A., Stokes, M., Jindia, T., Perna, S. K., Vassilakopoulos, T. (2026). Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD, + Pola-RCHP in patients (pts) with newly diagnosed aggressive B-cell lymphoma (a-BCL): Safety and 12-month (mo) efficacy results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7011